Pharmacological FGF21 signals to glutamatergic neurons to enhance leptin action and lower body weight during obesity
Objective: Fibroblast growth factor 21 (FGF21) is a peripherally-derived endocrine hormone that acts on the central nervous system (CNS) to regulate whole body energy homeostasis. Pharmacological administration of FGF21 promotes weight loss in obese animal models and human subjects with obesity. How...
Saved in:
Main Authors: | Kristin E. Claflin (Author), Andrew I. Sullivan (Author), Meghan C. Naber (Author), Kyle H. Flippo (Author), Donald A. Morgan (Author), Tate J. Neff (Author), Sharon O. Jensen-Cody (Author), Zhiyong Zhu (Author), Leonid V. Zingman (Author), Kamal Rahmouni (Author), Matthew J. Potthoff (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Conditional gene targeting using UCP1-Cre mice directly targets the central nervous system beyond thermogenic adipose tissues
by: Kristin E. Claflin, et al.
Published: (2022) -
FGF21 resistance is not mediated by downregulation of beta-klotho expression in white adipose tissue
by: Kathleen R. Markan, et al.
Published: (2017) -
BBSome ablation in SF1 neurons causes obesity without comorbidities
by: Mohamed Rouabhi, et al.
Published: (2021) -
Differential contribution of POMC and AgRP neurons to the regulation of regional autonomic nerve activity by leptin
by: Balyssa B. Bell, et al.
Published: (2018) -
Fasting, feasting and the glutamatergic synapse
by: Piya Ghose
Published: (2012)